{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:40:02Z","timestamp":1788316802045,"version":"build-2803163510"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Study Objectives<\/jats:title>\n                  <jats:p>This study assessed the utilization of potentially inappropriate medications (PIM) including oral sedative-hypnotic and atypical antipsychotic (OSHAA), healthcare resource utilization (HCRU), and costs among elderly individuals with insomnia and in the subpopulation with Alzheimer\u2019s disease (AD) who also had a diagnosis of insomnia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using a claims database containing International Classification of Diseases, 10th Revision (ICD-10) codes, the cohort included individuals aged\u2005\u2265\u200565 with incident insomnia (EI, N\u2005=\u2005152\u2005969) and AD insomnia subpopulation (ADI, N\u2005=\u20054888). The proportion of patients utilizing atypical antipsychotics or oral sedative-hypnotic medications, namely z-drugs, benzodiazepines, doxepin, dual orexin receptor antagonists (DORAs), and melatonin agonists, were assessed. Inappropriate OSHAA utilization was defined as per the American Geriatrics Society (AGS) Beers criteria. Multivariable models were utilized to compare HCRU and costs between PIM-OSHAA and no PIM-OSHAA groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among the EI cohort, z-drugs (13.39%) were the most commonly utilized OSHAA, and in the ADI cohort, it was AAPs (29.97%). PIM-OSHAA was utilized by 20% of the EI and 35% of the ADI cohorts. Patients with PIM-OSHAA use among the EI cohort had a higher annualized adjusted mean HCRU (pharmacy visits: 31.21 vs. 23.68; ambulatory and outpatient visits: 18.55 vs. 16.85) and costs, primarily due to medical costs (mean total cost: $36\u2005676.08 vs. $31\u2005346.54) compared to those without.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Substantial utilization of PIM-OSHAA was observed in EI and ADI cohorts. PIM-OSHAA use was associated with higher HCRU and costs. These findings underscore the importance of appropriate treatment strategies for insomnia in the elderly population especially in those with concurrent AD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/sleep\/zsaf003","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T14:21:22Z","timestamp":1737814882000},"source":"Crossref","is-referenced-by-count":3,"title":["Utilization of potentially inappropriate sedative-hypnotic and atypical antipsychotic medications among elderly individuals with insomnia and Alzheimer\u2019s disease"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6541-033X","authenticated-orcid":false,"given":"Farid","family":"Chekani","sequence":"first","affiliation":[{"name":"Merck & Co., Inc. , Rahway, NJ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti","family":"Mirchandani","sequence":"additional","affiliation":[{"name":"Complete HEOR Solutions (CHEORS) , Chalfont, PA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Zaki","sequence":"additional","affiliation":[{"name":"Complete HEOR Solutions (CHEORS) , Chalfont, PA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarnali","family":"Goswami","sequence":"additional","affiliation":[{"name":"Complete HEOR Solutions (CHEORS) , Chalfont, PA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4221-7801","authenticated-orcid":false,"given":"Manvi","family":"Sharma","sequence":"additional","affiliation":[{"name":"Complete HEOR Solutions (CHEORS) , Chalfont, PA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"key":"2025041104531627800_CIT0001","article-title":"Impact of the DSM-IV to DSM-5 changes on the national survey on drug use and health","volume-title":"CBHSQ Methodology Report","author":"Substance Abuse and Mental Health Services Administration","year":"2016"},{"issue":"1","key":"2025041104531627800_CIT0002","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11065-010-9154-6","article-title":"Sleep and sleep disorders in older adults","volume":"21","author":"Crowley","year":"2011","journal-title":"Neuropsychol Rev."},{"issue":"5","key":"2025041104531627800_CIT0003","doi-asserted-by":"publisher","first-page":"244","DOI":"10.9740\/mhc.2023.10.244","article-title":"Efficacy and safety of pharmacotherapy in chronic insomnia: a review of clinical guidelines and case reports","volume":"13","author":"Del Rio Verduzco","year":"2023","journal-title":"Ment Health Clin"},{"issue":"9","key":"2025041104531627800_CIT0004","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11920-016-0717-y","article-title":"An update on the use of sedative-hypnotic medications in psychiatric disorders","volume":"18","author":"Creado","year":"2016","journal-title":"Curr Psychiatry Rep."},{"issue":"suppl 2","key":"2025041104531627800_CIT0005","first-page":"3","article-title":"Atypical antipsychotics: sleep, sedation, and efficacy","volume":"6","author":"Miller","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"7","key":"2025041104531627800_CIT0006","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American geriatrics society 2023 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","author":"Bythe 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","journal-title":"J Am Geriatr Soc."},{"key":"2025041104531627800_CIT0007","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2147\/CEOR.S406137","article-title":"Benzodiazepine usage, healthcare resource utilization, and costs among older adults treated with common insomnia medications: a retrospective cohort study","volume":"15","author":"Wickwire","year":"2023","journal-title":"ClinicoEcon Outcom Res"},{"issue":"10","key":"2025041104531627800_CIT0008","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00228-019-02722-0","article-title":"2015 Beers Criteria and STOPP v2 for detecting potentially inappropriate medication in community-dwelling older people: prevalence, profile, and risk factors","volume":"75","author":"Blanco-Reina","year":"2019","journal-title":"Eur J Clin Pharmacol."},{"issue":"1","key":"2025041104531627800_CIT0009","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4140\/TCP.n.2018.48","article-title":"Use of 2015 beers criteria medications by older Medicare beneficiaries","volume":"33","author":"Patel","year":"2018","journal-title":"Consult Pharm."},{"key":"2025041104531627800_CIT0010","author":"Merative Marketscan Research Databases","year":"2024"},{"key":"2025041104531627800_CIT0011","doi-asserted-by":"publisher","first-page":"100204","DOI":"10.1016\/j.puhip.2021.100204","article-title":"Increasing rate of diagnosed childhood mental illness in the United States: incidence, prevalence and costs","volume":"2","author":"Tkacz","year":"2021","journal-title":"Public Health Pract"},{"issue":"1","key":"2025041104531627800_CIT0012","first-page":"2","article-title":"Identifying cases of sleep disorders through International Classification of Diseases (ICD) codes in administrative data","volume":"3","author":"Jolley","year":"2018","journal-title":"Int J Popul data Sci"},{"key":"2025041104531627800_CIT0013","author":"FDA"},{"issue":"4","key":"2025041104531627800_CIT0014","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1111\/bcp.15113","article-title":"Use of sedative-hypnotic medications and risk of dementia: a systematic review and meta-analysis","volume":"88","author":"AlDawsari","year":"2022","journal-title":"Br J Clin Pharmacol."},{"issue":"10","key":"2025041104531627800_CIT0015","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.5664\/jcsm.7370","article-title":"Use of sedative-hypnotics and mortality: a population-based retrospective cohort study","volume":"14","author":"Choi","year":"2018","journal-title":"J Clin Sleep Med."},{"issue":"4","key":"2025041104531627800_CIT0016","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/MLR.0000000000000326","article-title":"A new Elixhauser-based comorbidity summary measure to predict in-hospital mortality","volume":"53","author":"Thompson","year":"2015","journal-title":"Med Care."},{"key":"2025041104531627800_CIT0017","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fneur.2012.00073","article-title":"Behavioral and psychological symptoms of dementia","volume":"3","author":"Cerejeira","year":"2012","journal-title":"Front Neurol."},{"issue":"1","key":"2025041104531627800_CIT0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-019-1260-3","article-title":"Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis","volume":"19","author":"Aigbogun","year":"2019","journal-title":"BMC Neurol."},{"issue":"4","key":"2025041104531627800_CIT0019","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3233\/JAD-210713","article-title":"Incremental healthcare utilization and cost burden of comorbid insomnia in Alzheimer\u2019s disease patients","volume":"83","author":"Qureshi","year":"2021","journal-title":"J Alzheimers Dis."},{"issue":"7","key":"2025041104531627800_CIT0020","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/brainsci8070133","article-title":"Synthetic cannabinoid use in a case series of patients with psychosis presenting to acute psychiatric settings: clinical presentation and management issues","volume":"8","author":"Bonaccorso","year":"2018","journal-title":"Brain Sci"},{"issue":"10","key":"2025041104531627800_CIT0021","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1007\/s11606-021-06742-4","article-title":"Codifying social determinants of health: a gap in the ICD-10-CM","volume":"36","author":"Jacobs","year":"2021","journal-title":"J Gen Intern Med."},{"issue":"11","key":"2025041104531627800_CIT0022","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jamda.2020.06.006","article-title":"Direct medical costs of dementia with lewy bodies by disease complexity","volume":"21","author":"Espinosa","year":"2020","journal-title":"J Am Med Dir Assoc."},{"issue":"10","key":"2025041104531627800_CIT0023","doi-asserted-by":"publisher","first-page":"e0223255","DOI":"10.1371\/journal.pone.0223255","article-title":"Burden of treatment-resistant depression in Medicare: a retrospective claims database analysis","volume":"14","author":"Pilon","year":"2019","journal-title":"PLoS One."},{"issue":"3","key":"2025041104531627800_CIT0024","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3233\/JAD-180593","article-title":"Factors associated with length of stay in hospital patients with and without dementia","volume":"67","author":"M\u00f6llers","year":"2019","journal-title":"J Alzheimers Dis."},{"issue":"6","key":"2025041104531627800_CIT0025","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/gps.4037","article-title":"Grouping of behavioural and psychological symptoms of dementia","volume":"29","author":"Van Der Linde","year":"2014","journal-title":"Int J Geriatr Psychiatry."},{"issue":"1","key":"2025041104531627800_CIT0026","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3233\/ADR-210023","article-title":"Medications in patients with dementia and behavioral disturbance","volume":"5","author":"Zhong","year":"2021","journal-title":"Journal Alzheimer's Dis Rep"},{"key":"2025041104531627800_CIT0027","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev-publhealth-040617-013517","article-title":"Modeling health care expenditures and use","volume":"39","author":"Deb","year":"2018","journal-title":"Annu Rev Public Health."},{"issue":"5","key":"2025041104531627800_CIT0028","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1524-4733.2006.00122.x","article-title":"Analyses of cost data in economic evaluations conducted alongside randomized controlled trials","volume":"9","author":"Doshi","year":"2006","journal-title":"Value in Health"},{"issue":"11","key":"2025041104531627800_CIT0029","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1111\/jgs.16743","article-title":"Potentially inappropriate medications are associated with increased healthcare utilization and costs","volume":"68","author":"Clark","year":"2020","journal-title":"J Am Geriatr Soc."},{"issue":"3","key":"2025041104531627800_CIT0030","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"1","key":"2025041104531627800_CIT0031","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12991-017-0137-3","article-title":"Insomnia severity and its relationship with demographics, pain features, anxiety, and depression in older adults with and without pain: cross-sectional population-based results from the PainS65+ cohort","volume":"16","author":"Dragioti","year":"2017","journal-title":"Ann Gen Psychiatry"},{"issue":"6","key":"2025041104531627800_CIT0032","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1159\/000017198","article-title":"Behavioral and psychological symptoms in Alzheimer\u2019s disease. Relation between apathy and regional cerebral perfusion","volume":"10","author":"Benoit","year":"1999","journal-title":"Dement Geriatr Cogn Disord."},{"issue":"1","key":"2025041104531627800_CIT0033","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s12877-022-03240-y","article-title":"Prevalence of potentially inappropriate medications among old people with major neurocognitive disorder in 2012 and 2017","volume":"22","author":"Rangfast","year":"2022","journal-title":"BMC Geriatr."},{"issue":"1","key":"2025041104531627800_CIT0034","doi-asserted-by":"publisher","first-page":"zpab017","DOI":"10.1093\/sleepadvances\/zpab017","article-title":"Diagnosed or prescribed only? A national analysis of initial evaluation and management of insomnia among older adult Medicare beneficiaries","volume":"2","author":"Wickwire","year":"2021","journal-title":"SLEEP Adv"},{"issue":"12","key":"2025041104531627800_CIT0035","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.jamda.2023.09.013","article-title":"Prevalence and risk of behavioral symptoms among patients with insomnia and Alzheimer\u2019s disease: a retrospective database analysis","volume":"24","author":"Chekani","year":"2023","journal-title":"J Am Med Dir Assoc."},{"key":"2025041104531627800_CIT0036","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fphar.2021.695315","article-title":"Potentially inappropriate prescriptions of antipsychotics for patients with dementia","volume":"12","author":"Machado-Duque","year":"2021","journal-title":"Front Pharmacol."},{"issue":"5","key":"2025041104531627800_CIT0037","doi-asserted-by":"publisher","first-page":"310","DOI":"10.12788\/jhm.2739","article-title":"High prevalence of inappropriate benzodiazepine and sedative hypnotic prescriptions among hospitalized older adults","volume":"12","author":"Pek","year":"2017","journal-title":"J Hosp Med."},{"issue":"4","key":"2025041104531627800_CIT0038","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/ageing\/afaa067","article-title":"Potentially inappropriate medication use in older adults with mild-moderate Alzheimer\u2019s disease: prevalence and associations with adverse events","volume":"49","author":"Murphy","year":"2020","journal-title":"Age Ageing."},{"key":"2025041104531627800_CIT0039","author":"Roldan","year":"2018"},{"key":"2025041104531627800_CIT0040","author":"CMS","year":"2022"}],"container-title":["SLEEP"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/sleep\/advance-article-pdf\/doi\/10.1093\/sleep\/zsaf003\/61625322\/zsaf003.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/48\/4\/zsaf003\/61625322\/zsaf003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/48\/4\/zsaf003\/61625322\/zsaf003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:53:34Z","timestamp":1744347214000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sleep\/article\/doi\/10.1093\/sleep\/zsaf003\/7979181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,1,25]]},"published-print":{"date-parts":[[2025,4,11]]}},"URL":"https:\/\/doi.org\/10.1093\/sleep\/zsaf003","relation":{},"ISSN":["0161-8105","1550-9109"],"issn-type":[{"value":"0161-8105","type":"print"},{"value":"1550-9109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,1,25]]},"article-number":"zsaf003"}}